Skip to main content

Home
News
World
Sport
Entertainment
Business
Health
Technology

Menu

Home
News
World
Sport
Entertainment
Business
Health
Technology

Tag: Celosia

CTx1000 ALS Trial: First Patient Dosed in Phase 1b Study Targeting TDP-43 Protein

March 23, 2026

CTx1000 ALS Trial: First Patient Dosed in Phase 1b Study Targeting TDP-43 Protein

NewsList Directory is a comprehensive directory of news sources, media outlets, and publications worldwide. Discover trusted journalism from around the globe.

Quick Links

Privacy Policy
About Us
Accessibility statement
California Privacy Notice (CCPA/CPRA)
Contact
Cookie Policy
Disclaimer
DMCA Policy
Do not sell my info
EDITORIAL TEAM
Terms & Conditions

Browse by Location

GB
NZ
US

Connect With Us

© 2026 World Today News. All rights reserved. Your trusted global news source directory.

Privacy Policy Terms of Service

Web Analytics